Venlafaxine extended release - Sun Pharma Advanced Research Company
Latest Information Update: 23 Apr 2015
At a glance
- Originator Sun Pharma Advanced Research Company
- Class Antidepressants; Anxiolytics; Cyclohexanols; Dimethylamines; Small molecules
- Mechanism of Action Adrenergic uptake inhibitors; Serotonin uptake inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Depressive disorders